Micro-structurally detailed model of a therapeutic hydrogel injectate in a rat biventricular cardiac geometry for computational simulations

Computer Methods in Biomechanics and Biomedical Engineering

Volumn 18, Issue 3, 2015, Pages 325-331

  Sirry, Mazin S ^a   Davies, Neil H ^a   Kadner, Karen ^a   Dubuis, Laura ^a   Saleh, Muhammad G ^b   Meintjes, Ernesta M ^b   Spottiswoode, Bruce S ^b,c   Zilla, Peter ^a   Franz, Thomas ^a,d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d CENTRE FOR HIGH PERFORMANCE COMPUTING   (South Africa)

Author keywords

computational modelling; hydrogel; image based reconstruction; myocardial infarction; therapeutic injectate

Indexed keywords

CARDIOLOGY; HEART; HYDROGELS; MAGNETIC RESONANCE IMAGING; RATS;

CARDIAC MAGNETIC RESONANCE IMAGING; COMPUTATIONAL MODELLING; COMPUTATIONAL SIMULATION; COMPUTATIONAL STUDIES; IMAGE-BASED; MYOCARDIAL INFARCTION; STRUCTURAL DETAILS; THERAPEUTIC INJECTATE;

COMPUTATIONAL GEOMETRY;

BIOMATERIAL; MACROGOL; HYDROGEL;

ALGORITHM; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; CARDIAC GEOMETRY; CARDIOVASCULAR MAGNETIC RESONANCE; COMPUTER SIMULATION; END DIASTOLIC BIVENTRICULAR GEOMETRY; FINITE ELEMENT ANALYSIS; GEOMETRY; HEART FUNCTION; HISTOLOGY; IMAGING; INJECTION SITE; MATHEMATICAL MODEL; MICROSCOPIC ANATOMY; NONHUMAN; RAT; ANIMAL; HEART INFARCTION; HEART VENTRICLE REMODELING; HYDROGEL; INJECTION; MALE; PATHOPHYSIOLOGY; THERAPEUTIC USE; WISTAR RAT;

ANIMALS; BIOCOMPATIBLE MATERIALS; COMPUTER SIMULATION; HYDROGEL; INJECTIONS; MALE; MYOCARDIAL INFARCTION; RATS; RATS, WISTAR; VENTRICULAR REMODELING;

EID: 84908514231     PISSN: 10255842     EISSN: 14768259     Source Type: Journal    
DOI: 10.1080/10255842.2013.793765     Document Type: Article

References (26)

1. AHA. 2008. Heart disease and stroke statistics: our guide to current statistics and the supplement to our heart and stroke facts. Dallas, TX: American Heart Association.
2. ChristmanKL, FokHH, SieversRE, FangQ, LeeRJ. 2004. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng. 10(3–4):403–409.
3. ChristmanKL, VardanianAJ, FangQ, SieversRE, FokHH, LeeRJ. 2004. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol. 44(3):654–660.
4. DobnerS, BezuidenhoutD, GovenderP, ZillaP, DaviesN. 2009. A synthetic non-degradable polyethylene glycol hydrogel retards adverse post-infarct left ventricular remodeling. J Card Fail. 15(7):629–636.
5. GuccioneJM, SalahiehA, MoonlySM, KortsmitJ, WallaceAW, RatcliffeMB. 2003. Myosplint decreases wall stress without depressing function in the failing heart: a finite element model study. Ann Thorac Surg. 76(4):1171–1180, discussion 1180.
6. HuangNF, SieversRE, ParkJS, FangQ, LiS, LeeRJ. 2006. A rodent model of myocardial infarction for testing the efficacy of cells and polymers for myocardial reconstruction. Nat Protocols. 1(3):1596–1609.
7. IfkovitsJL, TousE, MinakawaM, MoritaM, RobbJD, KoomalsinghKJ, GormanJH, GormanRC, BurdickJA. 2010. Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proc Natl Acad Sci. 107(25):11507–11512.
8. JessupM, AbrahamWT, CaseyDE, FeldmanAM, FrancisGS, GaniatsTG, KonstamMA, ManciniDM, RahkoPS, SilverMA, et al., 2009. 2009 Focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the american college of cardiology foundation/american heart association task force on practice guidelines: developed in collaboration with the international society for heart and lung transplantation. Circulation. 119(14):1977–2016.
9. KadnerK, DobnerS, FranzT, BezuidenhoutD, SirryMS, ZillaP, DaviesNH. 2012. The beneficial effects of deferred delivery on the efficiency of hydrogel therapy post myocardial infarction. Biomaterials. 33(7):2060–2066.
10. KatzAM. 2009. Heart failure: pathophysiology, molecular biology and clinical management. Philadelphia, PA: Wolters Kluwer.
11. KawamotoA, TkebuchavaT, YamaguchiJ, NishimuraH, YoonYS, MillikenC, UchidaS, MasuoO, IwaguroH, MaH, et al., 2003. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation. 107(3):461–468.
12. KlodellCT, Jr, ArandaJM, Jr, McGiffinDC, RayburnBK, SunB, AbrahamWT, PaeWE, Jr, BoehmerJP, KleinH, HuthC. 2008. Worldwide surgical experience with the paracor heartnet cardiac restraint device. J Thorac Cardiovasc Surg. 135(1):188–195.
13. KofidisT, LeblDR, MartinezEC, HoytG, TanakaM, RobbinsRC. 2005. Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation. 112(9):I173–I177.
14. KortsmitJ, DaviesNH, MillerR, MacadangdangJR, ZillaP, FranzT. 2012. The effect of hydrogel injection on cardiac function and myocardial mechanics in a computational post-infarction model. Comput Methods Biomech Biomed Eng. 10.1080/10255842.2012.656611.
15. LandaN, MillerL, FeinbergMS, HolbovaR, ShacharM, FreemanI, CohenS, LeorJ. 2008. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation. 117(11):1388–1396.
16. MangiAA, NoiseuxN, KongD, HeH, RezvaniM, IngwallJS, DzauVJ. 2003. Mesenchymal stem cells modified with akt prevent remodeling and restore performance of infarcted hearts. Nat Med. 9(9):1195–1201.
17. NelsonDM, MaZ, FujimotoKL, HashizumeR, WagnerWR. 2011. Intra-myocardial biomaterial injection therapy in the treatment of heart failure: materials, outcomes and challenges. Acta Biomater. 7(1):1–15.
18. OmensJ, MayK, McCullochA. 1991. Transmural distribution of three-dimensional strain in the isolated arrested canine left ventricle. Am J Physiol Heart Circ Physiol. 261(3):H918–H928.
19. OpieLH, CommerfordPJ, GershBJ, PfefferMA. 2006. Controversies in ventricular remodelling. Lancet. 367(9507):356–367.
20. RuvinovE, LeorJ, CohenS. 2011. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials. 32(2):565–578.
21. SalehM, SharpS-K, AlhamudA, SpottiswoodeBS, van der KouweAJW, DaviesNH, FranzT, MeintjesEM. 2012. Long-term left ventricular remodelling in rat model of non-reperfused myocardial infarction: sequential MR imaging using a 3T clinical scanner. J Biomed Biotechnol. 2012:1–10.
22. TomitaS, MickleDA, WeiselRD, JiaZQ, TumiatiLC, AllidinaY, LiuP, LiRK. 2002. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg. 123(6):1132–1140.
23. WallST, WalkerJC, HealyKE, RatcliffeMB, GuccioneJM. 2006. Theoretical impact of the injection of material into the myocardium – a finite element model simulation. Circulation. 114(24):2627–2635.
24. WenkJF, EslamiP, ZhangZ, XuC, KuhlE, Gorman IiiJH, RobbJD, RatcliffeMB, GormanRC, GuccioneJM. 2011. A novel method for quantifying the in-vivo mechanical effect of material injected into a myocardial infarction. Ann Thorac Surg. 92(3):935–941.
25. WenkJF, WallST, PetersonRC, HelgersonSL, SabbahHN, BurgerM, StanderN, RatcliffeMB, GuccioneJM. 2009. A method for automatically optimizing medical devices for treating heart failure: designing polymeric injection patterns. J Biomech Eng. 131(12):121011.
26. WHO. 2008. The atlas of heart disease and stroke. Geneva: World Health Organization.